The Vanguard Group 13D/13G Filings for Dolby Laboratories, Inc. (DLB)

The Vanguard Group 13D and 13G filings for Dolby Laboratories, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-04-30
10:55 am
Purchase
2025-03-3113GDolby Laboratories, Inc.
DLB
The Vanguard Group7,535,722
12.310%
1,140,972increase
(+17.84%)
Filing
2024-02-13
5:02 pm
Purchase
2023-12-2913GDolby Laboratories, Inc.
DLB
The Vanguard Group6,394,750
10.800%
382,656increase
(+6.36%)
Filing
2023-03-10
07:59 am
Purchase
2023-02-2813GDolby Laboratories, Inc.
DLB
The Vanguard Group6,012,094
10.060%
48,422increase
(+0.81%)
Filing
2023-02-09
11:16 am
Sale
2022-12-3013GDolby Laboratories, Inc.
DLB
The Vanguard Group5,963,672
9.940%
-323,297decrease
(-5.14%)
Filing
2022-09-09
3:13 pm
Purchase
2022-08-3113GDolby Laboratories, Inc.
DLB
The Vanguard Group6,286,969
10.210%
129,265increase
(+2.10%)
Filing
2022-02-09
3:43 pm
Purchase
2021-12-3113GDolby Laboratories, Inc.
DLB
The Vanguard Group6,157,704
9.480%
217,718increase
(+3.67%)
Filing
2021-02-10
10:52 am
Purchase
2020-12-3113GDolby Laboratories, Inc.
DLB
The Vanguard Group5,939,986
9.170%
139,708increase
(+2.41%)
Filing